These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38069160)

  • 21. Periodontitis and Alzheimer's disease: oral systemic link still on the rise?
    Uppoor AS; Lohi HS; Nayak D
    Gerodontology; 2013 Sep; 30(3):239-42. PubMed ID: 22458804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.
    Ringman JM; Liang LJ; Zhou Y; Vangala S; Teng E; Kremen S; Wharton D; Goate A; Marcus DS; Farlow M; Ghetti B; McDade E; Masters CL; Mayeux RP; Rossor M; Salloway S; Schofield PR; Cummings JL; Buckles V; Bateman R; Morris JC;
    Brain; 2015 Apr; 138(Pt 4):1036-45. PubMed ID: 25688083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's disease.
    Wei X; Du P; Zhao Z
    Neurosci Lett; 2021 Oct; 763():136196. PubMed ID: 34437990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.
    Hayes JP; Logue MW; Sadeh N; Spielberg JM; Verfaellie M; Hayes SM; Reagan A; Salat DH; Wolf EJ; McGlinchey RE; Milberg WP; Stone A; Schichman SA; Miller MW
    Brain; 2017 Mar; 140(3):813-825. PubMed ID: 28077398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
    Shaw LM; Korecka M; Clark CM; Lee VM; Trojanowski JQ
    Nat Rev Drug Discov; 2007 Apr; 6(4):295-303. PubMed ID: 17347655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presenilin 1 intronic polymorphism is not associated with Alzheimer type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H; Yamada M
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):548-51. PubMed ID: 9576554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case-control study on family history of Alzheimer's disease].
    Yao J; Li H; Zhang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Feb; 23(1):54-6. PubMed ID: 12015112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
    Tripathi R; Kumar P
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neural changes in Alzheimer's disease from circuit to molecule: Perspective of optogenetics.
    Yang Q; Song D; Qing H
    Neurosci Biobehav Rev; 2017 Aug; 79():110-118. PubMed ID: 28522119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zebrafish as a tool in Alzheimer's disease research.
    Newman M; Verdile G; Martins RN; Lardelli M
    Biochim Biophys Acta; 2011 Mar; 1812(3):346-52. PubMed ID: 20920580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetics of familial Alzheimer's disease.
    St George-Hyslop PH; Haines JL; Polinsky RJ; Tanzi RE; Farrer L; Myers RH; Gusella JF
    Can J Neurol Sci; 1989 Nov; 16(4 Suppl):465-7. PubMed ID: 2680005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of interleukin-1 gene polymorphisms with Alzheimer's disease.
    Nicoll JA; Mrak RE; Graham DI; Stewart J; Wilcock G; MacGowan S; Esiri MM; Murray LS; Dewar D; Love S; Moss T; Griffin WS
    Ann Neurol; 2000 Mar; 47(3):365-8. PubMed ID: 10716257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic mechanism underlying the resilience to Alzheimer's disease and its prospect for clinical application].
    Zeng F; Ma Y; Wang J; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Dec; 39(12):1419-1423. PubMed ID: 36453972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease: the potential of epigenetic treatments and current clinical candidates.
    Coneys R; Wood IC
    Neurodegener Dis Manag; 2020 Jun; 10(3):543-558. PubMed ID: 32552286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin Mirrors Brain: A Chance for Alzheimer's Disease Research.
    Zouboulis CC; Makrantonaki E; Hossini AM
    Adv Exp Med Biol; 2021; 1339():371-380. PubMed ID: 35023127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Alzheimer's disease.
    Burke JR; Roses AD
    Int J Neurol; 1991-1992; 25-26():41-51. PubMed ID: 11980062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic linkage between Alzheimer's disease and type 2 diabetes.
    Nedjadi T; Haque A; Alam Q; Gan SH; Chaudhary AG; Abuzenadah AM; Damanhouri GA; Kamal MA
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):203-12. PubMed ID: 24059319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer's Disease.
    Bartolo ND; Mortimer N; Manter MA; Sanchez N; Riley M; O'Malley TT; Hooker JM
    ACS Chem Neurosci; 2022 Dec; 13(24):3641-3660. PubMed ID: 36473177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial DNA in pathogenesis of Alzheimer's and Parkinson's diseases.
    Maruszak A; Gaweda-Walerych K; Sołtyszewski I; Zekanowski C
    Acta Neurobiol Exp (Wars); 2006; 66(2):153-76. PubMed ID: 16886726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.